National Test Directory for Cancer
In October 2018, the National Test Directory for cancer was published. The Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which the tests are available, and the patients who will be eligible to access each test.
The East Genomic Laboratory Hub will facilitate and process testing for cancer in line with the National Directory.
June 2021 – and update on genomic testing
Over the last few weeks and months the East Genomic Laboratory Hub (East GLH) has seen a significant increase in the number of genomic tests for both rare disease and cancer ordered for a number of reasons.
Unfortunately this, coupled with our ability to finally process certain samples which had previously been put on hold during the COVID pandemic, is significantly affecting our usual turn-around times for the despatch of results. This delay is greatest for certain rare disease tests.
We apologise for the inconvenience and potential distress the delay of results may cause for patients and staff though we are asking all staff to please bear these delays in mind before chasing up any results; we will despatch results as soon as possible.
We are doing all we can to catch up with the backlog and get back to the national desired turn-around times, however, due to the size of the backlog this will take several months.
Many thanks for your patience.
East Genomic Laboratory Hub